Shopping Cart
- Remove All
Your shopping cart is currently empty
Tapinarof
🥰Excellent
Catalog No. T4644Cas No. 79338-84-4
Alias WBI 1001, GSK2894512, Benvitimod
Tapinarof (Benvitimod) is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease.
Tapinarof
🥰Excellent
Purity: 100%
Catalog No. T4644Alias WBI 1001, GSK2894512, BenvitimodCas No. 79338-84-4
Tapinarof (Benvitimod) is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | 32 € | In Stock | |
| 2 mg | 45 € | In Stock | |
| 5 mg | 73 € | In Stock | |
| 10 mg | 119 € | In Stock | |
| 25 mg | 230 € | In Stock | |
| 50 mg | 350 € | In Stock | |
| 100 mg | 521 € | In Stock | |
| 500 mg | 1.130 € | In Stock | |
| 1 mL x 10 mM (in DMSO) | 76 € | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Tapinarof"
Indole-3-carbinol
Indole-3-Methanol, I3C, 3-Indolemethanol
T2947700-06-1
Indole-3-carbinol (I3C), a naturally occurring, orally available cleavage product of the glucosinolate glucobrassicanin, inhibits NF-κB and IκBα kinase activation.
- 27 €
Size
QTY
Benzyl butyl phthalate
Cited
butyl phenylmethyl ester, Butyl benzyl phthalate, BBP, 1,2-benzenedicarboxylic acid
T064085-68-7
Benzyl butyl phthalate (1,2-benzenedicarboxylic acid) is used as a plasticizer for PVC.
- 38 €
Size
QTY
CitedNimodipine Cited
BAY-e 9736
T034366085-59-4
Nimodipine (BAY-e 9736), a 1, 4-dihydropyridine calcium channel blocker, acts primarily on vascular smooth muscle cells.
- 38 €
Size
QTY
CitedDiosmin
Venosmine, Diosmil, Barosmin
T0878520-27-4
Diosmin (Venosmine) is a bioflavonoid that strengthens vascular walls.
- 42 €
Size
QTY
Mexiletine hydrochloride
Mexiletine HCl, KOE-1173 (hydrochloride), KO1173
T10465370-01-4
Mexiletine hydrochloride (KOE-1173 hydrochloride) is a voltage-gated sodium channel blocker and a Class IB antiarrhythmic drug. Mexiletine hydrochloride exerts antiarrhythmic effects by inhibiting sodium current in myocardial cells, thereby reducing the rise rate of cardiac action potential (phase 0) and reducing the automaticity of Purkinje fibers.
- 33 €
Size
QTY
MeBIO
T21966667463-95-8
MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.
- 31 €
Size
QTY
Leflunomide
SU101, RS-34821, HWA486
T115975706-12-6
Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis.
- 37 €
Size
QTY
(-)-Perillaldehyde
T911218031-40-8
(-)-Perillaldehyde shows antibacterial activity.
- 28 €
Size
QTY
Carbidopa monohydrate
S(-)-Carbidopa, Carbidopa Hydrate
T214838821-49-7
Carbidopa monohydrate (S(-)-Carbidopa) is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
- 28 €
Size
QTY
Prochloraz
Sporgon, Prelude
T2062567747-09-5
Prochloraz (Prelude) is a broad-spectrum contact imidazole fungicide. Prochloraz inhibits human placental microsomal aromatase in vitro (IC50 = 40 nM). Prochloraz also acts as an estrogen receptor (IC50s = 25 μM) and androgen receptor (IC50 = 4 μM) antagonist, and activates aryl hydrocarbon receptors (EC50 = 1 μM).
- 32 €
Size
QTY
DiMNF
3',4'-Dimethoxy-αNF
T2272514756-24-2In house
DiMNF (3',4'-Dimethoxy-αNF) is a selective and potent modulator of the aryl hydrocarbon receptor (AHR) and an AHR ligand with anti-inflammatory activity that inhibits cytokine-mediated induction of complement factor genes.
- 55 €
Size
QTY
PD98059
Cited
PD 98059
T2623167869-21-8
PD98059 is an MEK inhibitor that inhibits MEK1 and MEK2 (IC50=2/50 μM) and is non-ATP-competitive. PD98059 is also antagonistic as a ligand for AHR. PD98059 inhibits autophagy.
- 32 €
Size
QTY
CitedSelect Batch
Purity:100%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | Tapinarof (Benvitimod) is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease. |
| Targets&IC50 | AhR:13 nM（EC50） |
| In vitro | Tapinarof activates the AhR pathway through direct binding, inducing dose-dependent nuclear translocation of AhR in immortalized keratinocytes (HaCaT). |
| In vivo | Tapinarof mediates its anti-inflammatory effects via the AhR pathway in IMQ-treated mice. In mice expressing AhR on a C57Bl/6 background, both Tapinarof and 6-formylindolo(3,2-b)carbazole (FICZ) significantly lower clinical inflammation scores. Conversely, AhR knockout (KO) mice exhibit no such anti-inflammatory response to Tapinarof. FICZ serves as a benchmark in these experiments, demonstrating comparable reduction in inflammation in wild-type mice, but ineffective in AhR KO mice. |
| Alias | WBI 1001, GSK2894512, Benvitimod |
| Molecular Weight | 254.32 |
| Formula | C17H18O2 |
| Cas No. | 79338-84-4 |
| Smiles | CC(C)c1c(O)cc(\C=C\c2ccccc2)cc1O |
| Relative Density. | 1.158 g/cm3 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (216.26 mM)  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Tapinarof | purchase Tapinarof | Tapinarof cost | order Tapinarof | Tapinarof chemical structure | Tapinarof in vivo | Tapinarof in vitro | Tapinarof formula | Tapinarof molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.